Gain Buy-In for CSTDs: A Personal Story from a Pharmacist Cancer Survivor
Friday, January 22 |
Mark Stanfield, BFA, PharmD, Oncology Pharmacy Specialist at Providence Hood River Cancer Center in Hood River, OR, shares his unique personal story of standing up for the safety of his health system’s patients as well as his own. After receiving a cancer diagnosis, Mark led an effort to update his acute care hospital’s closed system drug-transfer device (CSTD). In this webinar, he will outline the necessary steps to convert to a safer system, discussing the system’s benefits and advantages and providing pointers on how other pharmacies can gain buy-in and exercise influence, regardless of hospital bed size.
Mark A. Stanfield, BFA, PharmD, earned his PharmD from the University of Kansas School of Pharmacy in 2009 and earned a BFA in film and music at the Cincinnati Conservatory of Music at the University of Cincinnati in 1996. He is an Oncology Pharmacy Specialist at Providence Hood River Cancer Center in Hood River, OR.